Personalis, Inc. Accrued Liabilities, Current
Personalis, Inc. (PSNL) had Accrued Liabilities, Current of $1.47 million as of 2024-09-30, per its 10-Q filed 2024-11-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2024-11-06
- 2024-09-30: Accrued Liabilities, Current $1.47M.
- 2024-06-30: Accrued Liabilities, Current $2.41M.
- 2024-03-31: Accrued Liabilities, Current $1.13M.
- 2023-12-31: Accrued Liabilities, Current $858.00K.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2024-09-30 | $1.47M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $2.41M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $1.13M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $858.00K 10-Q · filed 2024-11-06 |
| 2023-09-30 | $1.98M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $789.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.02M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $1.70M 10-K · filed 2024-02-28 |
| 2022-09-30 | $5.52M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $4.72M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $3.21M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $883.00K 10-K · filed 2023-02-23 |
| 2021-09-30 | $977.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $435.00K 10-Q · filed 2021-08-04 |
| 2021-03-31 | $665.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | $313.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $343.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $297.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $268.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $689.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $352.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $547.00K 10-Q · filed 2019-08-13 |
| 2018-12-31 | $59.00K 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |